DeepMed Research

CENTRE LEON BERARD

🇫🇷France

Country: 🇫🇷France

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Assessment of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-guided Liver Surgery

Phase 1

Completed

Conditions: Liver Neoplasms

Interventions: Procedure: Fluobeam

First Posted Date: 2012-11-30

Last Posted Date: 2015-07-08

Lead Sponsor: Centre Leon Berard

Target Recruit Count: 48

Registration Number: NCT01738217

Locations: 🇫🇷
Centre Léon Bérard, Lyon Cedex 08, France

Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive

Phase 2

Completed

Conditions: Head and Neck Neoplasms
Neoplasm Metastasis
Recurrent Disease
Progressive Disease

Interventions: Drug: BKM120

First Posted Date: 2012-11-29

Last Posted Date: 2019-06-24

Lead Sponsor: Centre Leon Berard

Target Recruit Count: 58

Registration Number: NCT01737450

Locations: 🇫🇷
Hôpital BEAUJON, Clichy, France
🇫🇷
Centre Antoine LACASSAGNE, Nice, France
🇫🇷
Institut Curie, Paris, France

and more 6 locations

Xenon Combined With Intraoperative Thoracic Epidural Analgesia

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Drug: Desflurane
Drug: Xenon

First Posted Date: 2012-10-01

Last Posted Date: 2016-08-04

Lead Sponsor: Centre Leon Berard

Target Recruit Count: 31

Registration Number: NCT01696630

Locations: 🇫🇷
Centre Léon Bérard, LYON Cedex 08, France

Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma

Phase 2

Completed

Conditions: Locally Advanced Disease
Non-metastatic Disease
Non-small Cell Lung Cancer
Non-resectable Disease
Radiation Therapy

Interventions: Radiation: mid-position radiation strategy
Radiation: ITV

First Posted Date: 2012-07-09

Last Posted Date: 2021-02-05

Lead Sponsor: Centre Leon Berard

Target Recruit Count: 54

Registration Number: NCT01635270

Locations: 🇫🇷
Centre Léon Bérard, Lyon, France

Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway

Phase 1

Terminated

Conditions: Activation of the Sonic Hedgehog (SHH) Pathway
Histologically Confirmed Medulloblastoma

Interventions: Drug: Temozolomide
Drug: vismodegib

First Posted Date: 2012-05-17

Last Posted Date: 2019-05-21

Lead Sponsor: Centre Leon Berard

Target Recruit Count: 24

Registration Number: NCT01601184

Locations: 🇫🇷
Institut de Cancérologie de l'Ouest - René Gauducheau, St Herblain, Loire Atlantique, France
🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷
Institut Claudius Régaud (iuct-oncopole), Toulouse, Haute-Garonne, France

and more 12 locations

Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation

Not Applicable

Terminated

Conditions: Non Hodgkin Lymphoma

Interventions: Drug: Pegfilgrastim
Drug: Filgrastim

First Posted Date: 2012-02-29

Last Posted Date: 2016-11-01

Lead Sponsor: Centre Leon Berard

Target Recruit Count: 34

Registration Number: NCT01541072

Locations: 🇫🇷
Centre Leon Berard, Lyon, France
🇫🇷
CHU Clermont-Ferrand, Hôpital d'Estaing, Clermont-Ferrand, France

Study to Evaluate a High Intensity Focused Ultrasound (HIFU) Procedure in Patient With Liver Metastases

Not Applicable

Conditions: Neoplasm Metastasis

Interventions: Procedure: HIFU

First Posted Date: 2011-12-12

Last Posted Date: 2018-01-29

Lead Sponsor: Centre Leon Berard

Target Recruit Count: 38

Registration Number: NCT01489787

Locations: 🇫🇷
Centre Léon Bérard, Lyon, France

First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10

Phase 1

Terminated

Conditions: Sarcoma, Synovial

Interventions: Drug: OTSA101-DTPA-90Y level 1
Drug: OTSA101-DTPA-90Y level 3
Drug: OTSA101-DTPA-90Y level 2

First Posted Date: 2011-11-10

Last Posted Date: 2017-05-17

Lead Sponsor: Centre Leon Berard

Target Recruit Count: 20

Registration Number: NCT01469975

Locations: 🇫🇷
Centre Léon Bérard, LYON Cedex 08, France

Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Phase 2

Terminated

Conditions: Diffuse Large B Cell Lymphoma

Interventions: Drug: MK2206

First Posted Date: 2011-11-08

Last Posted Date: 2014-07-10

Lead Sponsor: Centre Leon Berard

Target Recruit Count: 22

Registration Number: NCT01466868

Locations: 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷
Centre Henri Mondor, Créteil, France
🇫🇷
CHRU, Lille, France

and more 10 locations

Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer
Metastasis

Interventions: Other: Blood sample for genetic analysis (Identification of germ line genetic factors that influence the risk of metastatic breast cancer)

First Posted Date: 2011-10-26

Last Posted Date: 2019-01-15

Lead Sponsor: Centre Leon Berard

Target Recruit Count: 1000

Registration Number: NCT01460186

Locations: 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷
Centre Antoine Lacassagne, Nice, France
🇫🇷
Hôpital Dupuytren, LIMOGES Cedex, France

and more 14 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy